Suresh Singh Yadav
Overview
Explore the profile of Suresh Singh Yadav including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalia P, Nair R, Yadav S
Discov Oncol
. 2025 Jan;
16(1):21.
PMID: 39776001
Colon cancer remains a significant health burden globally, necessitating deeper investigation. Identification and targeting of prognostic markers can significantly improve the current therapeutic approaches for colon cancer. The differential nuclear...
2.
Yadav S, Nair R, Singh K
Front Endocrinol (Lausanne)
. 2024 Feb;
15:1359605.
PMID: 38344663
No abstract available.
3.
Changotra H, Kaur S, Yadav S, Gupta G, Parkash J, Duseja A
Cell Biochem Funct
. 2022 Sep;
40(7):650-667.
PMID: 36062813
Autophagy, an intracellular conserved degradative process, plays a central role in the renewal/recycling of a cell to maintain the homeostasis of nutrients and energy within the cell. ATG5, a key...
4.
Wortzel I, Maik-Rachline G, Yadav S, Hanoch T, Seger R
iScience
. 2021 Jun;
24(6):102670.
PMID: 34189435
ERK1c is an alternatively spliced isoform of ERK1 that specifically regulates mitotic Golgi fragmentation, which allows division of the Golgi during mitosis. We have previously shown that ERK1c translocates to...
5.
Kumar M, Jaiswal R, Prasad R, Yadav S, Kumar A, Yadava P, et al.
Life Sci
. 2021 Jan;
269:118994.
PMID: 33417952
Aim: To study the role of PARP-1 in EMT of non-small cell lung carcinoma. Materials And Methods: We used H1299 and H460 lung cancer cells for knockdown study of PARP-1...
6.
Srivastav S, Anand B, Fatima M, Prajapati K, Yadav S, Kar K, et al.
ACS Chem Neurosci
. 2020 Oct;
11(22):3772-3785.
PMID: 33125229
Parkinson's disease (PD) is the most common progressive neurodegenerative disease known to impart bradykinesia leading to diverse metabolic complications. Currently, scarcity of effective drug candidates against this long-term devastating disorder...
7.
Yadav S, Kumar M, Varshney A, Yadava P
Life Sci
. 2019 Feb;
220:169-176.
PMID: 30716337
Aims: Insensitivity of cancer cells to therapeutic drugs is the most daunting challenge in cancer treatment. The mechanism of developing chemo-resistance is only partly understood to date. In continuation of...
8.
Flores K, Yadav S, Katz A, Seger R
Neuroendocrinology
. 2018 Sep;
108(2):121-131.
PMID: 30261516
The mitogen-activated protein kinase (MAPK) cascades are central signaling pathways that play a central role in the regulation of most stimulated cellular processes including proliferation, differentiation, stress response and apoptosis....
9.
Yadav S, Nair R, Yadava P
Med Hypotheses
. 2018 Apr;
115:50-53.
PMID: 29685197
Gene expression is crucial and tightly regulated to steer the development, differentiation, proliferation and even apoptosis of a cell. Each cell and tissue type shows a unique repertoire of transcription...
10.
Prasad C, Prasad S, Yadav S, Pandey L, Singh S, Pradhan S, et al.
Sci Rep
. 2017 Oct;
7(1):12876.
PMID: 28993682
PARP1 trapping at DNA lesion by pharmacological inhibitors has been exploited in several cancers exhibiting defects in DNA repair mechanisms. PARP1 hyperactivation is involved in therapeutic resistance in multiple cancers....